Wellpath to Offer Pear Therapeutics DTx for Addiction to New Outpatient Treatment Centers

Pear Therapeutics has announced collaboration with Wellpath Community Care Centers to bring its FDA-authorized digital therapeutics (DTx) to elevate the nation’s battle against the substance and opioid use crisis. Wellpath Community Care Centers can now offer Pear’s reSET® and reSET-O® products to provide same day, single centered comprehensive medical and behavioral services with 24/7 access to optimize clinician delivered medication-assisted treatment (MAT) for optimal outcomes.

Caption Health Raises $53 Million to Expand and Commercialize its FDA-Cleared, AI-Guided Ultrasound Technology

Caption Health, a leading medical artificial intelligence (AI) company, concluded its Series B funding round with $53 million to expand and commercialize its FDA-cleared, AI-guided ultrasound technology that improves patient access to high-quality and essential care. The strategy is to use this investment to scale commercial operations, continue to develop its AI technology platform, and form new partnerships. New clinical capabilities are planned with increased clinical adoption of the Caption AI platform.

MedRhythms Chronic Stroke Digital Therapeutic Receives FDA Breakthrough Designation

MedRhythms Inc., a digital therapeutics startup based in Portland, Maine, has received FDA breakthrough device designation for its Rhythmic Auditory Stimulation (RAS) treatment platform for people with chronic walking impairments due to stroke. This product is the first in the Company's pipeline of digital therapeutics for neurologic disease and injury.

FDA Issues EUA for First COVID-19 Standalone At-Home Sample Collection Kit

The FDA has issued an emergency use authorization (EUA) to Everlywell, Inc. for the Everlywell COVID-19 Test Home Collection Kit. Everlywell’s kit, a self-collected nasal swab, is authorized to be used by individuals at home who have been screened using an online questionnaire that is reviewed by a health care provider. This marks the first standalone sample collection kit to be granted a proper EUA by the FDA. The FDA has also authorized two COVID-19 diagnostic tests, performed at specific laboratories, for use with samples collected using the Everlywell COVID-19 Test Home Collection Kit. These tests have been authorized under separate, individual EUAs.

COVID-19 Digital Tools & Resources | Apple, Google Partner Up to Offer COVID-19 Contact Tracing

Apple, Google Partner Up to Offer COVID-19 Contact Tracing Recently Apple and Google partnered together on contract tracing to help slow the spread of COVID-19. Contact tracing makes it possible to combat the spread of the COVID-19 virus by alerting participants of potential exposure to someone who they have recently been in contact with, and … Continue reading COVID-19 Digital Tools & Resources | Apple, Google Partner Up to Offer COVID-19 Contact Tracing →

Healthcare Innovation: More Than Just Adopting Digital Technologies

As organizations consider implementing new technologies or digital therapeutics within their standard of care, the most undeniable element is that it represents powerful change. The demand for digital clinical workspaces will intensify as the natural productivity and mobility benefits become more integrated into health care delivery strategies.